Company: RPTX
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0000950170-25-030405
Chunk: 8

Company: Repare Therapeutics Inc.
Filing Date: 2025-03-03
Form: 10-K
Item: Item 16
Chunk 8
---
None.

146

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

    REPARE THERAPEUTICS INC.

    Date: March 3, 2025
     
    By:
    /s/ Lloyd M. Segal

    Lloyd M. Segal 

    President and Chief Executive Officer

147